Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Allison Matthews

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 14, 2026
Complex relationship between endocannabinoids, fatty acid amide hydrolase, and stress reactivity in human intrusive memories of analogue traumaMadeline A Jarvis, Allison Matthews, Ken Chia Min Hsu, et al.
Clinical Biochemistry|May 8, 2021
Is the diagnostic rate for the common subtypes of A1AT deficiency consistent across two Canadian Provinces?Mathew P Estey, Tania Tahooni, Tanya N Nelson, et al.
Cold Spring Harbor Molecular Case Studies|January 5, 2017
Optic atrophy, cataracts, lipodystrophy/lipoatrophy, and peripheral neuropathy caused by a de novo <i>OPA3</i> mutationStephanie C Bourne, Katelin N Townsend, Casper Shyr, et al.
Journal of Inherited Metabolic Disease|May 4, 2018
Integration of genomics and metabolomics for prioritization of rare disease variants: a 2018 literature reviewEmma Graham, Jessica Lee, Magda Price, et al.
Molecular Genetics and Metabolism|February 21, 2017
Novel homozygous PCK1 mutation causing cytosolic phosphoenolpyruvate carboxykinase deficiency presenting as childhood hypoglycemia, an abnormal pattern of urine metabolites and liver dysfunctionPäivi Vieira, Jessie Cameron, Elisa Rahikkala, et al.
Channels (Austin, Tex.)|October 30, 2025
<i>SCN3A</i>-related neurodevelopmental disorder: Clinical case reports and biophysical characterizationMohammad-Reza Ghovanloo, Cynthia Gershome, Robin van der Lee, et al.
Molecular Genetics and Metabolism|December 10, 2015
Secondary neurotransmitter deficiencies in epilepsy caused by voltage-gated sodium channelopathies: A potential treatment target?Gabriella A Horvath, Michelle Demos, Casper Shyr, et al.
Science (New York, N.Y.)|June 4, 2026
A stellar dynamical mass measurement of an inactive black hole at redshift 2Andrew B Newman, Meng Gu, Sirio Belli, et al.
The Journal of Experimental Medicine|July 31, 2025
ASXL1 deficiency causes epigenetic dysfunction, combined immunodeficiency, and EBV-associated lymphomaMaggie P Fu, Mehul Sharma, Pariya Yousefi, et al.
HGG Advances|May 23, 2022
Genome-wide sequencing and the clinical diagnosis of genetic disease: The CAUSES studyAlison M Elliott, Shelin Adam, Christèle du Souich, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 14, 2026
Complex relationship between endocannabinoids, fatty acid amide hydrolase, and stress reactivity in human intrusive memories of analogue traumaMadeline A Jarvis, Allison Matthews, Ken Chia Min Hsu, et al.
Clinical Biochemistry|May 8, 2021
Is the diagnostic rate for the common subtypes of A1AT deficiency consistent across two Canadian Provinces?Mathew P Estey, Tania Tahooni, Tanya N Nelson, et al.
Cold Spring Harbor Molecular Case Studies|January 5, 2017
Optic atrophy, cataracts, lipodystrophy/lipoatrophy, and peripheral neuropathy caused by a de novo <i>OPA3</i> mutationStephanie C Bourne, Katelin N Townsend, Casper Shyr, et al.
Journal of Inherited Metabolic Disease|May 4, 2018
Integration of genomics and metabolomics for prioritization of rare disease variants: a 2018 literature reviewEmma Graham, Jessica Lee, Magda Price, et al.
Molecular Genetics and Metabolism|February 21, 2017
Novel homozygous PCK1 mutation causing cytosolic phosphoenolpyruvate carboxykinase deficiency presenting as childhood hypoglycemia, an abnormal pattern of urine metabolites and liver dysfunctionPäivi Vieira, Jessie Cameron, Elisa Rahikkala, et al.
Channels (Austin, Tex.)|October 30, 2025
<i>SCN3A</i>-related neurodevelopmental disorder: Clinical case reports and biophysical characterizationMohammad-Reza Ghovanloo, Cynthia Gershome, Robin van der Lee, et al.
Molecular Genetics and Metabolism|December 10, 2015
Secondary neurotransmitter deficiencies in epilepsy caused by voltage-gated sodium channelopathies: A potential treatment target?Gabriella A Horvath, Michelle Demos, Casper Shyr, et al.
Science (New York, N.Y.)|June 4, 2026
A stellar dynamical mass measurement of an inactive black hole at redshift 2Andrew B Newman, Meng Gu, Sirio Belli, et al.
The Journal of Experimental Medicine|July 31, 2025
ASXL1 deficiency causes epigenetic dysfunction, combined immunodeficiency, and EBV-associated lymphomaMaggie P Fu, Mehul Sharma, Pariya Yousefi, et al.
HGG Advances|May 23, 2022
Genome-wide sequencing and the clinical diagnosis of genetic disease: The CAUSES studyAlison M Elliott, Shelin Adam, Christèle du Souich, et al.
Pageof 6